Financials • Specialty Insurers
$47.18 ▼ -0.88
(-1.83%)
MKT CAP: $6.61B • VOL: 363.6K
52W L $35 52W H $51
ROARABLE / RQD
B • 73/100
PIOTROSKI
4 / 9
ACT // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.24B | $1.20B | $1.15B |
| YoY Revenue Growth % | +2.8% | +4.2% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $0 | $0 | $0 |
| Operating Margin % | — | — | — |
| Net Income (GAAP) | $674.2M | $688.1M | $665.5M |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $724.5M | $686.3M | $632.0M |
| Capital Expenditures (CapEx) | — | — | — |
| Free Cash Flow (FCF) | $724.5M | $686.3M | $632.0M |
| FCF Margin % | 58.6% | 57.1% | 54.8% |
| Return on Invested Capital (ROIC %) | — | — | — |
| Cash & Short-Term Equivalents | $582.5M | $599.4M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $5.36B | $5.00B | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR ACT.